Praxis Bioresearch Obtains FDA Clearance On the IND Application for Its Lead Candidate PRX-P4-003 In Alzheimer’s Disease Apathy
29. Oktober 2024 07:48 ET
|
Praxis Bioresearch, Inc.
LOS ANGELES, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Praxis Bioresearch reports that the United States Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for...
Praxis Bioresearch Awarded $2.9 Million Fast-Track SBIR Grant for Development of Novel Therapy for Apathy in Alzheimer’s Disease
05. August 2021 04:00 ET
|
Praxis Bioresearch, LLC
LOS ANGELES, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Praxis is proud to announce to be the recipient of a Fast-Track SBIR award to develop treatment for apathy in Alzheimer’s Disease. The award, in its...
HelixBind Awarded $3MM NIH Grant to Support Testing of Its RaPID Diagnostic Platform for Invasive Infections Associated with Sepsis
17. Juni 2021 08:30 ET
|
HelixBind
BOXBOROUGH, Mass., June 17, 2021 (GLOBE NEWSWIRE) -- HelixBind, which is developing an innovative diagnostic platform to revolutionize care for invasive infections such as sepsis, announced today it...
Scanwell Health Awarded NIH Grant to Accelerate Development of its Smartphone-Enabled, At-Home Test for Chronic Kidney Disease
21. September 2020 09:00 ET
|
Scanwell Health
LOS ANGELES, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Scanwell Health, a Los Angeles-based company that makes healthcare quick and easy by offering at-home lab tests, has been awarded a $1.6M National...
P2D Bioscience Receives NIH Funding to Develop Drugs for Lung Disease
19. Juli 2011 10:31 ET
|
P2D Bioscience
CINCINNATI, OH and MUMBAI, INDIA--(Marketwire - Jul 19, 2011) - P2D Bioscience (P2D, Inc.), a pharmaceutical development company, announced today that the company has received a $320,000 grant from...
P2D Bioscience Awarded NIH Grant to Develop PD2007
22. Juni 2011 11:06 ET
|
P2D Bioscience
CINCINNATI, OH and MUMBAI, INDIA--(Marketwire - Jun 22, 2011) - ...